Work

A Phase I/II adaptive design to determine the optimal treatment regimen from a set of combination immunotherapies in high-risk melanoma

Year: 2015

Type: article

Source: Contemporary Clinical Trials

DOI: 10.1016/j.cct.2015.01.016

Authors: Nolan A. Wages, Craig L. Slingluff, Gina R. Petroni

Institution: University of Virginia

Language: English

Topic: Statistical Methods in Clinical Trials

Subfield: Statistics and Probability

Field: Mathematics

Domain: Physical Sciences

SDG: Good health and well-being

Open Access status: green

Funders: Melanoma Research Alliance, National Cancer Institute, Cairo University, National Cancer Institute

Awards: G3428986451, Phase I Designs for Combined Immunotherapies in Cancer, G8189391976, Designs for phase I trials in heterogeneous groups

OpenAlex ID: W2058033125

FWCI: 3.264

Cites: 34

Cited by: 27

Related to: 10